The univariate and multivariate Cox regression analyses were repeated in the subgroup of patients with high-grade serous carcinomas, in which meth-HOXA9 remained significant of outcome (Supplementary Materials, Tables S3 and S4). This evidence concerns the gene HOXA9 and serous adenocarcinoma.